Form 4: Kestra Medical Technologies Director Sells Shares
Insider Transaction (Form 4)
Kevin C Reilly, a Director of Kestra Medical Technologies, Ltd., sold 2,932 shares of common stock on September 8, 2026 for $25.13 per share.
Summary
- Open-market sale: disposed of 2,932 Common Shares at $25.13 ($73,677) on September 8, 2026; holds 5,368 after (Direct).
- Grant/award: acquired 7,217 Common Shares on September 9, 2026; holds 12,585 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $73,677 of stock on the open market.
Insider Transactions
Kevin C Reilly — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Open-market sale | Common Shares | 2,932 | $25 | $73.7K | 5,368 |
| 2026-09-09 | Grant/award | Common Shares | 7,217 | — | — | 12,585 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Open-market sale (2,932 shares) |
| 2026-09-09 | Grant/award (7,217 shares) |
Keywords
insider transaction, Form 4, KMTS, KESTRA MEDICAL TECHNOLOGIES, LTD., bearish, Kevin C Reilly
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.